Finance

Lists
Why is CAMP down ३.०३%?
Dive Deeper
CAMP:NASDAQ
CAMP4 Therapeutics Corp
US$ ३.८४
-३.०३%
(-०.१२) 1D
US$ ३.८४
०.००% (०.००)
After hours
Closed: अक्टोबर ७, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAMP...
Open
US$ ३.८५
High
US$ ४.१२
Low
US$ ३.८४
Mkt. cap
२४.१० करोड
Avg. vol.
३.५१ लाख
Volume
०.००
52-wk high
US$ ७.७५
52-wk low
US$ २.८६
EPS
-US$ २.२०
Shares outstanding
६.२८ करोड
No. of employees
४८
Open
US$ ३.८५
High
US$ ४.१२
Low
US$ ३.८४
Mkt. cap
२४.१० करोड
Avg. vol.
३.५१ लाख
Volume
०.००
52-wk high
US$ ७.७५
52-wk low
US$ २.८६
EPS
-US$ २.२०
Shares outstanding
६.२८ करोड
No. of employees
४८
News stories
From web sources and news partners
About CAMP4 Therapeutics Corp
CEO-
Employees४८
Founded२०१५
Headquarters-
Sector-
Websitecamp4tx.com
Analyst ratings
Based on 5 analysts giving stock ratings to CAMP in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CAMP in the last 3 months.
Highest
Current US$ ३.८४
US$ १५.०० (+२९०.६२%)
Average
US$ ९.०० (+१३४.३८%)
Lowest
US$ ६.०० (+५६.२५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yun Zhong
Wedbush
Buy
Maintained
US$ ८.००
+१०८.३%
09/29/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
US$ १५.००
+२९०.६%
09/29/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
US$ ६.००
+५६.३%
09/29/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
09/29/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$ ७.००
+८२.३%
09/28/2026
Anupam Rama
J.P. Morgan
Buy
Upgraded
US$ ९.००
+१३४.४%
06/22/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
US$ ७.००
+८२.३%
04/14/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
US$ ९.००
+१३४.४%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७.९५ लाख
३.४८ लाख
१२.९४ लाख
१७.७९ लाख
Cost of goods sold
९३.५६ लाख
८३.५७ लाख
१.०२ करोड
१.०८ करोड
Cost of revenue
९३.५६ लाख
८३.५७ लाख
१.०२ करोड
१.०८ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४५.९६ लाख
४७.६७ लाख
४२.०५ लाख
४३.४२ लाख
Operating expense
४५.९६ लाख
४७.६७ लाख
४२.०५ लाख
४३.४२ लाख
Total operating expenses
१.४० करोड
१.३१ करोड
१.४४ करोड
१.५२ करोड
Operating income
-१.३२ करोड
-१.२८ करोड
-१.३१ करोड
-१.३४ करोड
Other non operating income
-१८.६९ लाख
-२.८२ करोड
-६१.७० लाख
-२.१० करोड
EBT including unusual items
-१.५१ करोड
-४.०३ करोड
-१.८३ करोड
-३.३५ करोड
EBT excluding unusual items
-१.४६ करोड
-४.०३ करोड
-१.८३ करोड
-३.३५ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.५१ करोड
-४.०३ करोड
-१.८३ करोड
-३.३५ करोड
Net profit margin
-१,८९९.२५%
-११,५७५.८६%
-१,४१६.६२%
-१,८८४.७७%
Earnings per share
-०.५४
-०.२३
-०.२१
-०.२२
Interest and investment income
४.२३ लाख
७.१६ लाख
९.१० लाख
८.०७ लाख
Interest expense
-२.०० हजार
-
-
-
Net interest expenses
४.२१ लाख
७.१६ लाख
९.१० लाख
८.०७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.२७ करोड
-१.२४ करोड
-१.२६ करोड
-१.२९ करोड
Gain or loss from assets sale
६७.०० हजार
१.९१ लाख
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू